Meperidine Hydrochloride Injection Shortage
Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.
| Company | Brand name | Status | Last updated |
|---|---|---|---|
| Hospira, Inc., a Pfizer Company | DEMEROL | Current | 09/09/2026 |
| Hospira, Inc., a Pfizer Company | — | Current | 09/09/2026 |
| Hospira, Inc., a Pfizer Company | — | Current | 09/09/2026 |
| Hospira, Inc., a Pfizer Company | DEMEROL | Current | 09/09/2026 |
| Hikma Pharmaceuticals USA, Inc. | MEPERIDINE HYDROCHLORIDE | Current | 09/03/2026 |
| Hikma Pharmaceuticals USA, Inc. | MEPERIDINE HYDROCHLORIDE | Current | 09/03/2026 |
| Hikma Pharmaceuticals USA, Inc. | MEPERIDINE HYDROCHLORIDE | Current | 09/03/2026 |
| Hospira, Inc., a Pfizer Company | DEMEROL | Current | 08/24/2026 |
| Hospira, Inc., a Pfizer Company | — | Current | 08/24/2026 |
| Hospira, Inc., a Pfizer Company | — | Current | 08/24/2026 |